MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q1 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $29,518,000 | -2.9% | 788,631 | +13.9% | 0.05% | -1.9% |
| Q4 2015 | $30,387,000 | +6448.9% | 692,168 | +5491.0% | 0.05% | +5200.0% |
| Q3 2015 | $464,000 | +121.0% | 12,380 | +100.8% | 0.00% | – |
| Q2 2015 | $210,000 | +288.9% | 6,166 | +306.5% | 0.00% | – |
| Q1 2015 | $54,000 | -98.7% | 1,517 | -98.7% | 0.00% | -100.0% |
| Q4 2014 | $4,077,000 | -28.1% | 117,049 | -20.4% | 0.01% | -30.0% |
| Q3 2014 | $5,670,000 | -43.9% | 147,014 | -43.4% | 0.01% | -44.4% |
| Q2 2014 | $10,105,000 | -19.9% | 259,627 | -18.2% | 0.02% | -18.2% |
| Q1 2014 | $12,609,000 | +37.7% | 317,261 | -8.5% | 0.02% | +29.4% |
| Q4 2013 | $9,160,000 | +57.3% | 346,644 | +54.3% | 0.02% | +70.0% |
| Q3 2013 | $5,824,000 | +9.6% | 224,717 | +13.7% | 0.01% | 0.0% |
| Q2 2013 | $5,312,000 | – | 197,691 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |